Montelucaste Vitória (Montelukast)

Montelukast, the active ingredient in Montelucaste Vitória, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is indicated for the management of asthma, allergic rhinitis and exercise‑induced bronchoconstriction in patients who require a non‑steroidal option. GNH USA supplies Montelucaste Vitória as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast acts on the leukotriene pathway to control airway inflammation and bronchoconstriction. - Asthma: helps prevent chronic symptoms and reduces the frequency of exacerbations. - Allergic rhinitis: alleviates nasal congestion, sneezing and itching caused by seasonal allergens. - Exercise‑induced bronchoconstriction: reduces airway narrowing that occurs during physical activity.

Montelucaste Vitória may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain often reported. - Abdominal pain: discomfort or cramps in the stomach area. - Cough: occasional irritation of the throat. - Nausea: feeling of queasiness. - Dizziness: transient light‑headedness. - Fatigue: unusual tiredness.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema or swelling. - Mood changes: depression, anxiety or suicidal thoughts. - Hepatic enzyme elevation: abnormal liver function tests. - Stevens‑Johnson syndrome: severe skin reaction. - Eosinophilic granulomatosis with polyangiitis: rare vasculitis. - Anaphylaxis: life‑threatening systemic allergic response.

When prescribing Montelucaste Vitória, clinicians should consider several safety measures. - Monitor asthma control: assess symptoms regularly to ensure adequate management. - Hypersensitivity: avoid in patients with known allergy to montelukast or any tablet excipients. - Liver impairment: use cautiously and monitor hepatic function. - Pregnancy: category unknown; discuss potential risks with a healthcare professional. - Concomitant drugs: review for possible interactions before initiating therapy. - Store below 25°C: keep in the original pack, protect from moisture.

Montelucaste Vitória can interact with other medicines, requiring attention to the interaction severity.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase montelukast plasma levels. - Phenobarbital: can reduce therapeutic effect by inducing metabolism.

Moderate Interactions (Monitor Closely): - CYP2C9 inhibitors (e.g., fluconazole): may modestly raise drug concentrations. - Other leukotriene modifiers: combined use can increase risk of adverse effects. - Warfarin: occasional reports of altered INR; monitor coagulation parameters.